Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stabilityJoel Simrén, Nicholas J. Ashton, Henrik Zetterberg et al.|Alzheimer s & Dementia|2022Cited by 81
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settingsHanna Huber, Laia Montoliu‐Gaya, Kaj Blennow et al.|Alzheimer s & Dementia|2024Cited by 44
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathologyHanna Huber, Nicholas J. Ashton, Laia Montoliu-Gaya et al.|Nature Medicine|2026Cited by 11